Nina Paulshus Sundlisæter

Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis

Maria Karolina Jonsson, Nina Paulshus Sundlisæter, Hilde Haugedal Nordal et al. · Annals of the Rheumatic Diseases · 2017 · 60 citations

Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes

Nina Paulshus Sundlisæter, Anna‐Birgitte Aga, Inge Christoffer Olsen et al. · Annals of the Rheumatic Diseases · 2018 · 33 citations · Full text

Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol

Nina Paulshus Sundlisæter, Inge Christoffer Olsen, Anna‐Birgitte Aga et al. · Lara D. Veeken · 2018 · 28 citations · Full text

Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy

Ulf Sundin, Nina Paulshus Sundlisæter, Anna‐Birgitte Aga et al. · RMD Open · 2021 · 27 citations · Full text

Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission

Siri Lillegraven, Nina Paulshus Sundlisæter, Anna‐Birgitte Aga et al. · JAMA · 2021 · 26 citations · Full text